Evidence map›Paper›PMID 41065334›Full record

ArticleeLife2025

Reassessing the link between adiposity and head and neck cancer: a Mendelian randomization study.

Fernanda Morales Berstein, Jasmine Khouja, Mark Gormley, Elmira Ebrahimi, Shama Virani, James D McKay, Paul Brennan, Tom G Richardson, Caroline L Relton, George Davey Smith and 3 more

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Fernanda Morales BersteinMRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID https://orcid.org/0000-0002-8237-2021
Jasmine KhoujaMRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID https://orcid.org/0000-0002-7944-2981
Mark GormleyMRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID https://orcid.org/0000-0001-5733-6304
Elmira EbrahimiGenomic Epidemiology Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID https://orcid.org/0000-0003-0910-3447
Shama ViraniGenomic Epidemiology Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID https://orcid.org/0000-0002-1163-432X
James D McKayGenomic Epidemiology Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Paul BrennanGenomic Epidemiology Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Tom G RichardsonMRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID https://orcid.org/0000-0002-7918-2040
Caroline L ReltonMRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID https://orcid.org/0000-0003-2052-4840
George Davey SmithMRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID https://orcid.org/0000-0002-1407-8314
M Carolina BorgesMRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID https://orcid.org/0000-0001-7785-4547
Tom DuddingMRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID https://orcid.org/0000-0003-3756-040X
Rebecca C RichmondMRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.ORCID https://orcid.org/0000-0003-0574-5071

Funding

Germline risk of oral and oropharyngeal cancers across diverse populationsR03DE030257 · NIDCR · INTERNATIONAL AGENCY FOR RES ON CANCER · PI VIRANI, SHAMA · 2021 to 2022
$222k
British Heart Foundation AA/18/1/34219Cancer Research UK C18281/A29019EU Horizon 2020 grant Agreement number 825771Medical Research Council MC_UU_00011/5Medical Research Council MC_UU_00032/1Medical Research Council MC_UU_00032/5Medical Research Council MC_UU_00032/7NIDCR National Institutes of Dental and Craniofacial Health R03DE030257NIDCR NIH HHS R03 DE030257Wellcome TrustWellcome Trust 10.35802/224982World Health Organization 001
6 · The paper itself

Abstract

Background: Adiposity has been associated with an increased risk of head and neck cancer (HNC). Although body mass index (BMI) has been inversely associated with HNC risk among smokers, this is likely due to confounding. Previous Mendelian randomization (MR) studies could not fully discount causality between adiposity and HNC. Hence, we aimed to revisit this using the largest genome-wide association study (GWAS) of HNC available, which has more granular data on HNC subsites. Methods: We assessed the genetically predicted effects of BMI (N=806,834), waist-to-hip ratio (WHR; N=697,734) and waist circumference (N=462,166) on the risk of HNC (N=12,264 cases) and its subsites using a two-sample MR framework. We used inverse variance weighted (IVW) MR and multiple sensitivity analyses, including multivariable MR (MVMR), to explore the direct effects of the adiposity measures on HNC, while accounting for smoking behaviour (a well-known HNC risk factor). Results: In univariable MR, higher genetically predicted BMI increased the risk of overall HNC (IVW OR = 1.17 per 1-SD higher BMI, 95% CI 1.02-1.34). However, the IVW effect was attenuated when smoking was included in the MVMR model (OR accounting for comprehensive smoking index = 0.96 per 1-SD higher BMI, 95% CI 0.80-1.15). Furthermore, we did not find a link between genetically predicted WHR (IVW OR = 1.05 per 1-SD higher WHR, 95% CI 0.89-1.24) or waist circumference and HNC risk (IVW OR = 1.01 per 1-SD higher waist circumference, 95% CI 0.85-1.21). Conclusions: Our findings suggest that adiposity does not play a major role in HNC risk. Funding: FMB was supported by a Wellcome Trust PhD studentship in Molecular, Genetic and Lifecourse Epidemiology (224982/Z/22/Z). RCR was supported by a Cancer Research UK grant (C18281/A29019). MCB is supported by a University of Bristol Vice Chancellor's Fellowship, the British Heart Foundation (AA/18/1/34219) and the UK Medical Research Council (MC_UU_00032/5). GDS works within the MRC Integrative Epidemiology Unit at the University of Bristol, which is supported by the Medical Research Council (MC_UU_00032/1). CLR was supported by the Medical Research Council (MC_UU_00011/5) and by a Cancer Research UK (C18281/A29019) programme grant (the Integrative Cancer Epidemiology Programme). SV was funded by an EU Horizon 2020 grant (agreement number 825771) and NIDCR National Institutes of Dental and Craniofacial Health (R03DE030257). JK works in a unit that receives support from the University of Bristol, a Cancer Research UK grant (C18281/A29019) and the UK Medical Research Council (grant number: MC_UU_00032/7).

Indexed as

AdiposityHead and Neck NeoplasmsAdultAgedBody Mass IndexFemaleGenome-Wide Association StudyHumansMaleMendelian Randomization AnalysisMiddle AgedRisk FactorsWaist CircumferenceWaist-Hip Ratiobody mass indexepidemiologyglobal healthhead and neck cancerhumanmendelian randomizationsmokingwaist circumferencewaist-to-hip ratio

Identifiers

PMID41065334
PMCPMC12510682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.